- Home
- COTY vs ZLAB Comparison
COTY vs ZLAB Comparison
Compare COTY & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COTY
- ZLAB
- Stock Information
- Founded
- COTY 1904
- ZLAB 2013
- Country
- COTY United States
- ZLAB China
- Employees
- COTY N/A
- ZLAB N/A
- Industry
- COTY Package Goods/Cosmetics
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- COTY Consumer Discretionary
- ZLAB Health Care
- Exchange
- COTY Nasdaq
- ZLAB Nasdaq
- Market Cap
- COTY 3.5B
- ZLAB 3.4B
- IPO Year
- COTY 2013
- ZLAB 2017
- Fundamental
- Price
- COTY $4.22
- ZLAB $32.30
- Analyst Decision
- COTY Hold
- ZLAB Buy
- Analyst Count
- COTY 17
- ZLAB 6
- Target Price
- COTY $5.77
- ZLAB $57.22
- AVG Volume (30 Days)
- COTY 13.1M
- ZLAB 831.7K
- Earning Date
- COTY 11-05-2025
- ZLAB 11-11-2025
- Dividend Yield
- COTY N/A
- ZLAB N/A
- EPS Growth
- COTY N/A
- ZLAB N/A
- EPS
- COTY N/A
- ZLAB N/A
- Revenue
- COTY $5,892,900,000.00
- ZLAB $427,799,000.00
- Revenue This Year
- COTY $2.43
- ZLAB $42.62
- Revenue Next Year
- COTY $3.66
- ZLAB $55.12
- P/E Ratio
- COTY N/A
- ZLAB N/A
- Revenue Growth
- COTY N/A
- ZLAB 32.56
- 52 Week Low
- COTY $3.67
- ZLAB $20.17
- 52 Week High
- COTY $9.70
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- COTY 44.80
- ZLAB 47.53
- Support Level
- COTY $4.01
- ZLAB $26.67
- Resistance Level
- COTY $4.24
- ZLAB $33.06
- Average True Range (ATR)
- COTY 0.16
- ZLAB 1.38
- MACD
- COTY 0.01
- ZLAB 0.15
- Stochastic Oscillator
- COTY 53.68
- ZLAB 77.14
About COTY Coty Inc.
Coty is a global beauty maker that generates 65% of sales from prestige beauty products (primarily fragrances) and 35% from mass makeup, skin care, and fragrance. For the fragrance business, Coty licenses luxury and high-end brands including Gucci, Burberry, Hugo Boss, Davidoff, and Calvin Klein. In contrast, its consumer cosmetics business focuses on acquired mass brands such as CoverGirl, Max Factor, Rimmel, Sally Hansen, and Bourjois. It also collaborates with social media celebrity Kylie Jenner to manage makeup products bearing her name. By region, Coty generates close to 48% of sales from Europe, 40% from the Americas, and 12% from Asia-Pacific. German investment firm JAB is a controlling shareholder, with a 54% stake as of June 2025.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.